Home / Letter From The Editor / Editor’s Note: New Series on SMA’s, Unexpected Side-Effects and More

Editor’s Note: New Series on SMA’s, Unexpected Side-Effects and More

Mar 22, 2011
1,477 views
 

According to almost every clinician I talk to, it is becoming harder and harder to have enough time with our patients and get reimbursed for it. This is especially true for diabetes patients and is bound to get worse as patients only want to come one time to get help for multiple diagnoses. We have been working with some physicians over the past year to help deliver better care and improve reimbursement by using Shared Medical Appointments (SMA). Now Pfizer has put all the information and resources together in one program and we have that for you. Over the next few weeks you will have everything you need to begin SMA’s in your practice. This week we start with Understanding SMA’s: An Introduction to Group Office Visits.

This week’s Homerun Slides start a series on the Cost-Effectiveness of Treatment Strategies for Comorbid Diabetes and Dyslipidemia and offer up slides to help you explain why treatment choices are important in these diseases.

 

And while we are on the subject of dyslipidemias, this week’s Disaster Averted focuses on how sometimes combination medications can deliver much more than expected.